Ypsomed Holding AG operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ypsomed Holding AG with three other
medical equipment manufacturers in Europe:
Medacta Group SA
sales of 345.12 million Swiss Francs [US$351.45 million]
(2.82 billion Danish Kroner [US$408.87 million]
of which 35%
was Anaesthesia), and
Consort Medical Plc
based in the United Kingdom
(£305.10 million [US$398.30 million]
of which 59%
During the year ended March of 2019, sales at
Ypsomed Holding AG were 453.77 million Swiss Francs (US$462.08 million).
decrease of 2.7%
versus 2018, when the company's sales were 466.12 million Swiss Francs.
Contributing to the drop in overall sales was the 11.0% decline
in Delivery Systems, from 315.19 million Swiss Francs to 280.43 million Swiss Francs.
There were also decreases in sales in
Other Products (down 4.5% to 17.61 million Swiss Francs)
However, these declines were partially offset by the increase in sales of
Diabetes Care (up 17.5% to 155.73 million Swiss Francs)